Targeting apoptosis pathways in lung cancer.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Cancer Letters

• Publication date

  2013-05-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.canlet.2010.09.012PMID 20974517
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The hallmarks of cancer

  2012cited by this paper
• TRAIL receptor targeting therapies for non-small cell lung cancer: current status and perspectives.

  2010cited by this paper
• Phase 1b study of dulanermin (recombinant human Apo2L/TRAIL) in combination with paclitaxel, carboplatin, and bevacizumab in patients with advanced non-squamous non-small-cell lung cancer.

  2010cited by this paper
• Doxorubicin and etoposide sensitize small cell lung carcinoma cells expressing caspase-8 to TRAIL

  2010cited by this paper
• Phase I and pharmacokinetic study of lexatumumab (HGS-ETR2) given every 2 weeks in patients with advanced solid tumors.

  2010cited by this paper
• A Phase I Safety and Pharmacokinetic Study of the Death Receptor 5 Agonistic Antibody PRO95780 in Patients with Advanced Malignancies

  2010cited by this paper
• Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor-1 and receptor-2 agonists for cancer therapy

  2010cited by this paper
• Playing the DISC: turning on TRAIL death receptor-mediated apoptosis in cancer.

  2010cited by this paper
• AT-101, a Pan-Bcl-2 Inhibitor, Leads to Radiosensitization of Non-small Cell Lung Cancer

  2010cited by this paper
• Mapatumumab, a Fully Human Agonistic Monoclonal Antibody That Targets TRAIL-R1, in Combination with Gemcitabine and Cisplatin: a Phase I Study

  2009cited by this paper
• A small molecule inhibitor of XIAP induces apoptosis and synergises with vinorelbine and cisplatin in NSCLC

  2009cited by this paper
• Increased expression of inhibitor of apoptosis proteins, survivin and XIAP, in non-small cell lung carcinoma.

  2009cited by this paper
• Phase I Study of YM155, a Novel Survivin Suppressant, in Patients with Advanced Solid Tumors

  2009cited by this paper
• Phase I trial of AEG35156 administered as a 7-day and 3-day continuous intravenous infusion in patients with advanced refractory cancer.

  2009cited by this paper
• Multicenter phase II trial of YM155, a small-molecule suppressor of survivin, in patients with advanced, refractory, non-small-cell lung cancer.

  2009cited by this paper
• Apogossypol derivatives as antagonists of antiapoptotic Bcl-2 family proteins

  2009cited by this paper
• Alterations in the Noxa/Mcl-1 axis determine sensitivity of small cell lung cancer to the BH3 mimetic ABT-737

  2009cited by this paper
• Tumour suppression by p53: the importance of apoptosis and cellular senescence

  2009cited by this paper
• Safety and efficacy of AMG 655 in combination with paclitaxel and carboplatin (PC) in patients with advanced non-small cell lung cancer (NSCLC).

  2009cited by this paper
• Mapatumumab, an antibody targeting TRAIL-R1, in combination with paclitaxel and carboplatin in patients with advanced solid malignancies: results of a phase I and pharmacokinetic study.

  2009cited by this paper
• Synthesis and evaluation of Apogossypol atropisomers as potential Bcl-xL antagonists.

  2009cited by this paper
• Evolving treatment algorithms for advanced non-small-cell lung cancer: 2009 looking toward 2012.

  2009cited by this paper
• A phase Ib trial of Bcl-2 inhibitor obatoclax in combination with carboplatin and etoposide for previously untreated patients with extensive-stage small cell lung cancer (ES-SCLC).

  2009cited by this paper
• AT-101 or placebo (P) with docetaxel (D) in second-line NSCLC with gene signature biomarker development.

  2009cited by this paper
• Survivin, cancer networks and pathway-directed drug discovery

  2008cited by this paper
• Targeting Bcl-2 family members with the BH3 mimetic AT-101 markedly enhances the therapeutic effects of chemotherapeutic agents in in vitro and in vivo models of B-cell lymphoma.

  2008cited by this paper
• ABT-737 Induces Expression of the Death Receptor 5 and Sensitizes Human Cancer Cells to TRAIL-induced Apoptosis*

  2008cited by this paper
• ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor.

  2008cited by this paper
• Phase I/II study of AT-101 in combination with topotecan in patients with relapsed or refractory small cell lung cancer after prior platinum containing first line chemotherapy

  2008cited by this paper
• Lung cancer screening: the way forward

  2008cited by this paper
• Therapeutic efficacy of ABT-737, a selective inhibitor of BCL-2, in small cell lung cancer.

  2008cited by this paper
• Phase I trial of LBY135, a monoclonal antibody agonist to DR5, alone and in combination with capecitabine in advanced solid tumors

  2008cited by this paper
• The role of survivin on overall survival of non-small cell lung cancer, a meta-analysis of published literatures.

  2008cited by this paper
• A small molecule pan-Bcl-2 family inhibitor, GX15-070, induces apoptosis and enhances cisplatin-induced apoptosis in non-small cell lung cancer cells

  2008cited by this paper
• Histone deacetylase inhibitors: mechanisms of cell death and promise in combination cancer therapy.

  2008cited by this paper
• Directing cancer cells to self-destruct with pro-apoptotic receptor agonists

  2008cited by this paper
• Lung cancer.

  2008cited by this paper
• A Phase I Pharmacokinetic and Pharmacodynamic Correlative Study of the Antisense Bcl-2 Oligonucleotide G3139, in Combination with Carboplatin and Paclitaxel, in Patients with Advanced Solid Tumors

  2008cited by this paper
• Phase I and pharmacokinetic study of YM155, a small-molecule inhibitor of survivin.

  2008cited by this paper
• Mimicking the BH3 domain to kill cancer cells

  2008cited by this paper
• IAP-targeted therapies for cancer

  2008cited by this paper
• Phase 2 study of mapatumumab, a fully human agonistic monoclonal antibody which targets and activates the TRAIL receptor-1, in patients with advanced non-small cell lung cancer.

  2008cited by this paper
• Discovery of an orally bioavailable small molecule inhibitor of prosurvival B-cell lymphoma 2 proteins.

  2008cited by this paper
• Radiosensitizing Effect of YM155, a Novel Small-Molecule Survivin Suppressant, in Non–Small Cell Lung Cancer Cell Lines

  2008cited by this paper
• Randomized phase II Study of carboplatin and etoposide with or without the bcl-2 antisense oligonucleotide oblimersen for extensive-stage small-cell lung cancer: CALGB 30103.

  2008cited by this paper
• TRAIL-induced survival and proliferation of SCLC cells is mediated by ERK and dependent on TRAIL-R2/DR5 expression in the absence of caspase-8.

  2008cited by this paper
• Circulating Biomarkers of Cell Death After Treatment with the BH-3 Mimetic ABT-737 in a Preclinical Model of Small-Cell Lung Cancer

  2008cited by this paper
• Gefitinib-Induced Killing of NSCLC Cell Lines Expressing Mutant EGFR Requires BIM and Can Be Enhanced by BH3 Mimetics

  2007cited by this paper
• The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells.

  2007cited by this paper
• Influence of Bcl-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737.

  2007cited by this paper
• Targeting BCL‐2 family proteins to overcome drug resistance in non‐small cell lung cancer

  2007cited by this paper
• Bortezomib, but not cisplatin, induces mitochondria-dependent apoptosis accompanied by up-regulation of noxa in the non–small cell lung cancer cell line NCI-H460

  2007cited by this paper
• Phase I pharmacokinetic and biologic correlative study of mapatumumab, a fully human monoclonal antibody with agonist activity to tumor necrosis factor-related apoptosis-inducing ligand receptor-1.

  2007cited by this paper
• Phase 1 and Pharmacokinetic Study of Lexatumumab in Patients with Advanced Cancers

  2007cited by this paper
• Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis

  2007cited by this paper
• Role of XIAP in inhibiting cisplatin-induced caspase activation in non-small cell lung cancer cells: a small molecule Smac mimic sensitizes for chemotherapy-induced apoptosis by enhancing caspase-3 activation.

  2007cited by this paper
• TRAIL therapy in non–small cell lung cancer cells: sensitization to death receptor–mediated apoptosis by proteasome inhibitor bortezomib

  2007cited by this paper
• YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts.

  2007cited by this paper
• ‘Seed’ analysis of off-target siRNAs reveals an essential role of Mcl-1 in resistance to the small-molecule Bcl-2/Bcl-XL inhibitor ABT-737

  2007cited by this paper
• Cancer Statistics, 2006

  2006cited by this paper
• Valproic acid, an antiepileptic drug with histone deacetylase inhibitory activity, potentiates the cytotoxic effect of Apo2L/TRAIL on cultured thoracic cancer cells through mitochondria-dependent caspase activation.

  2006cited by this paper
• Proapoptotic multidomain Bcl-2/Bax-family proteins: mechanisms, physiological roles, and therapeutic opportunities

  2006cited by this paper
• Competing Interests: The authors

  2006cited by this paper
• Rapid and profound potentiation of Apo2L/TRAIL-mediated cytotoxicity and apoptosis in thoracic cancer cells by the histone deacetylase inhibitor Trichostatin A: the essential role of the mitochondria-mediated caspase activation cascade

  2006cited by this paper
• Preclinical Characterization of AEG35156/GEM 640, a Second-Generation Antisense Oligonucleotide Targeting X-Linked Inhibitor of Apoptosis

  2006cited by this paper
• Origins and selection of p53 mutations in lung carcinogenesis.

  2005cited by this paper
• Mechanisms of resistance to TRAIL-induced apoptosis in cancer

  2005cited by this paper
• An inhibitor of Bcl-2 family proteins induces regression of solid tumours

  2005cited by this paper
• Cisplatin activates Akt in small cell lung cancer cells and attenuates apoptosis by survivin upregulation

  2005cited by this paper
• Nuclear survivin predicts recurrence and poor survival in patients with resected nonsmall cell lung carcinoma

  2005cited by this paper
• Nuclear localization of survivin is a positive prognostic factor for survival in advanced non-small-cell lung cancer.

  2004cited by this paper
• Antitumor Efficacy of Oblimersen Bcl-2 Antisense Oligonucleotide Alone and in Combination with Vinorelbine in Xenograft Models of Human Non–Small Cell Lung Cancer

  2004cited by this paper
• A phase I trial of a Bcl-2 antisense (G3139) and weekly docetaxel in patients with advanced breast cancer and other solid tumors.

  2004cited by this paper
• Survivin as a therapeutic target for radiation sensitization in lung cancer.

  2004cited by this paper
• Cell death: critical control points.

  2004cited by this paper
• Inhibition of anti-apoptotic Bcl-2 family proteins by natural polyphenols: new avenues for cancer chemoprevention and chemotherapy.

  2004cited by this paper
• A small molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell death.

  2004cited by this paper
• XIAP and survivin as therapeutic targets for radiation sensitization in preclinical models of lung cancer

  2004cited by this paper
• Review Cell Death: Critical Control Points Another Line of Evidence for the Importance of Caspases in Cell Death Came From

  2004cited by this paper
• A Small Molecule Smac Mimic Potentiates TRAIL- and TNFα-Mediated Cell Death

  2004cited by this paper
• Structural biology of the Bcl-2 family of proteins.

  2004cited by this paper
• Discovery, characterization, and structure-activity relationships studies of proapoptotic polyphenols targeting B-cell lymphocyte/leukemia-2 proteins.

  2003cited by this paper
• Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis

  2003cited by this paper
• Silencing of death receptor and caspase-8 expression in small cell lung carcinoma cell lines and tumors by DNA methylation

  2003cited by this paper
• Apo2L/TRAIL and its death and decoy receptors

  2003cited by this paper
• Expression of TRAIL and TRAIL death receptors in stage III non-small cell lung cancer tumors.

  2003cited by this paper
• Differential Inactivation of Caspase-8 in Lung Cancers

  2002cited by this paper
• IAP proteins: blocking the road to death's door

  2002cited by this paper
• Apoptosis: target of cancer therapy.

  2002cited by this paper
• Loss of expression of death-inducing signaling complex (DISC) components in lung cancer cell lines and the influence of MYC amplification

  2002cited by this paper
• Expression of inhibitor of apoptosis proteins in small- and non-small-cell lung carcinoma cells.

  2002cited by this paper
• Defining characteristics of Types I and II apoptotic cells in response to TRAIL.

  2002cited by this paper
• Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics.

  2002cited by this paper
• Towards a Genetic-Based Classification of Human Lung Cancer

  2001cited by this paper
• A novel bispecific antisense oligonucleotide inhibiting both bcl-2 and bcl-xL expression efficiently induces apoptosis in tumor cells.

  2000cited by this paper
• Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition.

  2000cited by this paper
• The biochemistry of apoptosis

  2000cited by this paper
• Induction of apoptosis in lung‐cancer cells following bcl‐xL anti‐sense treatment

  2000cited by this paper
• Chemotherapy triggers apoptosis in a caspase-8-dependent and mitochondria-controlled manner in the non-small cell lung cancer cell line NCI-H460.

  2000cited by this paper
• A novel anti-apoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers.

  1999cited by this paper

• Exploring natural products as Bcl-2 inhibitors for acute myeloid leukemia therapy using In vitro, STD-NMR spectroscopy, and In silico approaches.

  2026cites this paper
• Cell Death, Molecular Targeted Therapies, and Metabolic Reprogramming in EGFR-Mutant Lung Cancer

  2025cites this paper
• Mechanistic insights into DEHP-induced progression of non-small cell lung cancer based on network toxicology and molecular docking

  2025cites this paper
• Advancing the understanding of the role of apoptosis in lung cancer immunotherapy: Global research trends, key themes, and emerging frontiers

  2025cites this paper
• Novel Camptothecin Derivative 9c with Enhanced Antitumor Activity via NSA2-EGFR-P53 Signaling Pathway

  2025cites this paper
• Integrating network pharmacology and experimental validation to explore the potential mechanism by which resveratrol acts on osimertinib resistance in lung cancer

  2025cites this paper
• Obatoclax enhances TRAIL-induced apoptosis in non-small-cell-lung-cancer cells by increasing TRAIL receptor expression, priming for mitochondrial apoptosis and reducing XIAP levels

  2025cites this paper
• UPLC-Q-TOF/MS-based serum metabolomics revealed anti-tumor mechanism of ethanol-soluble acidic components from Camellia oleifera cake and synergy with PD-1 inhibitor

  2025cites this paper
• Elucidating the anti-cancer potential of Cinnamomum tamala essential oil against non-small cell lung cancer: A multifaceted approach involving GC-MS profiling, network pharmacology, and molecular dynamics simulations

  2024cites this paper
• Effects of bipolar irreversible electroporation with different pulse durations in a prostate cancer mouse model

  2024cites this paper
• Evaluating Antibiofilm, Cytotoxic and Apoptotic Activities of Scutellaria brevibracteata subsp. brevibracteata Essential Oil

  2023cites this paper
• Orchestrating smart therapeutics to achieve optimal treatment in small cell lung cancer: recent progress and future directions

  2023cites this paper
• Fate and Efficacy of Engineered Allogeneic Stem Cells Targeting Cell Death and Proliferation Pathways in Primary and Brain Metastatic Lung Cancer

  2023influential citation
• Carotenoids for lung cancer chemoprevention and chemotherapy: Promises and controversies.

  2023cites this paper
• Enhanced chemotherapeutic efficacy of docetaxel in human lung cancer cell line via GLUT1 inhibitor

  2023cites this paper
• Anti-Cancer Effect of Neural Stem Cells Transfected with Carboxylesterase and sTRAIL Genes in Animals with Brain Lesions of Lung Cancer

  2023cites this paper
• Systematic analysis of apoptosis-related genes in the prognosis of lung squamous cell carcinoma: a combined single-cell RNA sequencing study

  2023cites this paper
• Regression of Lung Cancer in Mice by Intranasal Administration of SARS-CoV-2 Spike S1

  2022cites this paper
• Chitosan-alginate nanoparticles of cabazitaxel: Design, dual-receptor targeting and efficacy in lung cancer model.

  2022cites this paper
• Cinnamaldehyde Suppressed EGF-Induced EMT Process and Inhibits Ovarian Cancer Progression Through PI3K/AKT Pathway

  2022cites this paper
• Investigation of the anticancer and apoptotic effect of Micromeria congesta under in vitro conditions and detection of related genes by real-time PCR

  2022cites this paper
• Discovery and identification of a novel small molecule BCL-2 inhibitor that binds to the BH4 domain

  2022cites this paper
• Silver nanoparticles synthesized by Euphorbia hirta exhibited antibacterial activity and induced apoptosis through downregulation of PI3Kγ mediated PI3K/Akt/mTOR/p70S6K in human lung adenocarcinoma A549 cells

  2022cites this paper
• Correlation between oncogene integrator complex subunit 7 and a poor prognosis in lung adenocarcinoma

  2022cites this paper
• Akt/mTOR Targeting Activity of Resveratrol Derivatives in Non-Small Lung Cancer

  2022cites this paper
• Novel mechanism of napabucasin, a naturally derived furanonaphthoquinone: apoptosis and autophagy induction in lung cancer cells through direct targeting on Akt/mTOR proteins

  2022cites this paper
• An Annexin V-FITC-Propidium Iodide-Based Method for Detecting Apoptosis in a Non-Small Cell Lung Cancer Cell Line.

  2021cites this paper
• Sample-Specific Models for Precision Medicine

  2021cites this paper
• In vitro evaluation of the antiproliferative activity of Carpobrotus edulis on human neuroblastoma cells

  2021cites this paper
• Caspase Cascade Activation During Apoptotic Cell Death of Human Lung Carcinoma Cells A549 Induced by Marine Sponge Callyspongia aerizusa

  2021cites this paper
• Lenvatinib Inhibits AKT/NF-κB Signaling and Induces Apoptosis Through Extrinsic/Intrinsic Pathways in Non-small Cell Lung Cancer

  2021cites this paper
• OTT_A_264600 9599..9609

  2020cites this paper
• Restoration of Mal overcomes the defects of apoptosis in lung cancer cells

  2020cites this paper
• OTUD7B suppresses Smac mimetic-induced lung cancer cell invasion and migration via deubiquitinating TRAF3

  2020cites this paper
• Design, Synthesis, In vitro and In silico Evaluation of New Hydrazonebased Antitumor Agents as Potent Akt Inhibitors

  2020cites this paper
• MiR-101-3p and Syn-Cal14.1a Synergy in Suppressing EZH2-Induced Progression of Breast Cancer

  2020cites this paper
• A new series of benzoxazole‐based SIRT1 modulators for targeted therapy of non‐small‐cell lung cancer

  2020cites this paper
• The Effects of Newly Synthesized Platinum(IV) Complexes on Cytotoxicity and Radiosensitization of Human Tumour Cells In Vitro

  2020cites this paper
• Discriminative Subtyping of Lung Cancers from Histopathology Images via Contextual Deep Learning

  2020cites this paper
• Immunotherapy with Monoclonal Antibodies in Lung Cancer of Mice: Oxidative Stress and Other Biological Events

  2019cites this paper
• Activation of death receptor, DR5 and mitochondria-mediated apoptosis by a 3,4,5-trimethoxybenzyloxy derivative in wild-type and p53 mutant colorectal cancer cell lines

  2019cites this paper
• Citronellol Induces Necroptosis of Human Lung Cancer Cells via TNF-α Pathway and Reactive Oxygen Species Accumulation

  2019cites this paper
• EXERTED BY MONOCLONAL ANTIBODIES IN THE TREATMENT OF LUNG CANCER IN MICE

  2019cites this paper
• Trans‐3,5,4´‐trimethoxystilbene reduced gefitinib resistance in NSCLCs via suppressing MAPK/Akt/Bcl‐2 pathway by upregulation of miR‐345 and miR‐498

  2019cites this paper
• Cytotoxic and apoptosis-inducing effects of Sutherlandia frutescens in neuroblastoma cells

  2019cites this paper
• ATP1A1 Integrates AKT and ERK Signaling via Potential Interaction With Src to Promote Growth and Survival in Glioma Stem Cells

  2019cites this paper
• Drug Delivery Strategies For The Treatment Of Advanced Lung Cancer And Various Lung Metastases

  2018cites this paper
• TNF receptor‐associated factor 1 as a biomarker for assessment of non‐small cell lung cancer metastasis and overall survival

  2018cites this paper
• Inhibitory Effect of Kurarinone on Growth of Human Non-small Cell Lung Cancer: An Experimental Study Both in Vitro and in Vivo Studies

  2018cites this paper
• miR-33a inhibits cell proliferation and invasion by targeting CAND1 in lung cancer

  2018cites this paper
• Efficacy and mechanism of steep pulse irreversible electroporation technology on xenograft model of nude mice: a preclinical study

  2018cites this paper
• Interferon-γ and Smac mimetics synergize to induce apoptosis of lung cancer cells in a TNFα-independent manner

  2018cites this paper
• Targeting Polo-like kinase 1 and TRAIL enhances apoptosis in non-small cell lung cancer

  2018cites this paper
• Tripartite motif‐containing 37 (TRIM37) promotes the aggressiveness of non‐small‐cell lung cancer cells by activating the NF‐κB pathway

  2018cites this paper
• Marsdenia tenacissima extract induces apoptosis and suppresses autophagy through ERK activation in lung cancer cells

  2018cites this paper
• Increased KIF15 Expression Predicts a Poor Prognosis in Patients with Lung Adenocarcinoma

  2018cites this paper
• Effect of trail C1595T variant and gene expression on the pathogenesis of non-small cell lung cancer

  2018influential citation
• Design, synthesis and in vitro evaluation of new thiosemicarbazone derivatives as potential anticancer agents

  2018cites this paper
• Oxymatrine induces A549 human non‑small lung cancer cell apoptosis via extrinsic and intrinsic pathways.

  2017cites this paper
• RKIP reduction enhances radioresistance by activating the Shh signaling pathway in non-small-cell lung cancer

  2017cites this paper
• Enhancement of death receptor-mediated apoptosis in multiple myeloma cells

  2017influential citation
• Integrated High Throughput Analysis Identifies GSK3 as a Crucial Determinant of p53-Mediated Apoptosis in Lung Cancer Cells

  2017cites this paper
• HAT1 induces lung cancer cell apoptosis via up regulating Fas

  2017cites this paper
• Theabrownin Inhibits Cell Cycle Progression and Tumor Growth of Lung Carcinoma through c-myc-Related Mechanism

  2017cites this paper
• β-elemene regulates endoplasmic reticulum stress to induce the apoptosis of NSCLC cells through PERK/IRE1α/ATF6 pathway.

  2017cites this paper
• TRAIL-coated lipid-nanoparticles overcome resistance to soluble recombinant TRAIL in non-small cell lung cancer cells

  2016cites this paper
• Surfactant-based drug delivery systems for treating drug-resistant lung cancer

  2016cites this paper
• Reduced tumor burden through increased oxidative stress in lung adenocarcinoma cells of PARP-1 and PARP-2 knockout mice.

  2016cites this paper
• Cinobufagin inhibits tumor growth by inducing intrinsic apoptosis through AKT signaling pathway in human nonsmall cell lung cancer cells

  2016cites this paper
• Nedaplatin sensitization of cisplatin-resistant human non-small cell lung cancer cells.

  2016cites this paper
• Apoptosis Activation in Human Lung Cancer Cell Lines by a Novel Synthetic Peptide Derived from Conus californicus Venom

  2016cites this paper
• TRIM 9 is up-regulated in human lung cancer and involved in cell proliferation and apoptosis

  2016cites this paper
• Essential oil of Curcuma aromatica induces apoptosis in human non-small-cell lung carcinoma cells

  2016cites this paper
• Anti-Proliferative and Apoptosis-Inducing Effect of Theabrownin against Non-small Cell Lung Adenocarcinoma A549 Cells

  2016cites this paper
• Anticancer activity of glucomoringin isothiocyanate in human malignant astrocytoma cells.

  2016cites this paper
• MicroRNA-31 inhibits lung adenocarcinoma stem-like cells via down-regulation of MET-PI3K-Akt signaling pathway.

  2016cites this paper
• How Venom from the Magnificent Sea Anemone, Heteractis magnifica, Kills Breast and Lung Cancer Cells

  2016cites this paper
• Antiproliferative and apoptotic activities of extracts of Asclepias subulata

  2015cites this paper
• Improving therapeutic approaches for the treatment of Non-small Cell Lung Cancer using an ex-vivo explant culture system

  2015cites this paper
• Knockdown of NF‐κB p65 subunit expression suppresses growth of nude mouse lung tumour cell xenografts by inhibition of Bcl‐2 apoptotic pathway

  2015cites this paper
• Xanthohumol induces apoptosis and S phase cell cycle arrest in A549 non-small cell lung cancer cells

  2015influential citation
• Knockdown of NF-κB p65 subunit expression suppresses growth of nude mouse lung tumor cell xenografts by activation of Bax apoptotic pathway.

  2015cites this paper
• FLLL12 induces apoptosis in lung cancer cells through a p53/p73-independent but death receptor 5-dependent pathway.

  2015cites this paper
• The novel thymidylate synthase inhibitor trifluorothymidine (TFT) and TRAIL synergistically eradicate non-small cell lung cancer cells

  2014cites this paper
• Identificación mediante inmunohistoquímica de factores pronósticos biomoleculares en el carcinoma broncogénico no microcítico en estadio precoz resecado

  2014cites this paper
• Anti-cancer effect of neural stem cells transfected with carboxylesterase and sTRAIL genes in animal model of metastatic brain tumor from lung cancer

  2014cites this paper
• The cyclooxygenase-2/thromboxane A2 pathway: a bridge from rheumatoid arthritis to lung cancer?

  2014cites this paper
• Synergistic anti-tumor effects of the combination of a benzofuroxan derivate and sorafenib on NCI-H460 human large cell lung carcinoma cells.

  2014cites this paper
• Mechanisms for steep pulse irreversible electroporation technology to kill human large cell lung cancer cells L9981.

  2014cites this paper
• Antiproliferative activities of halogenated thieno[3,2-d]pyrimidines.

  2014cites this paper
• A Novel Small-Molecule YLT205 Induces Apoptosis in Human Colorectal Cells via Mitochondrial Apoptosis Pathway In Vitro and Inhibits Tumor Growth In Vivo

  2014cites this paper
• Prognostic value of circulating C-reactive protein levels in patients with non-small cell lung cancer: a systematic review with meta-analysis.

  2014cites this paper
• A randomized, double-blind, placebo-controlled phase 2 study of tigatuzumab (CS-1008) in combination with carboplatin/paclitaxel in patients with chemotherapy-naïve metastatic/unresectable non-small cell lung cancer.

  2013cites this paper
• Ionizing Radiation Potentiates Dihydroartemisinin-Induced Apoptosis of A549 Cells via a Caspase-8-Dependent Pathway

  2013cites this paper
• Effect of Embelin on TRAIL receptor 2 mAb-induced apoptosis of TRAIL-resistant A549 non-small cell lung cancer cells.

  2013cites this paper
• Anticancer activity of β-Elemene and its synthetic analogs in human malignant brain tumor cells.

  2013cites this paper
• Embelin and TRAIL Receptor 2 mAb-induced Apoptosis of TRAIL-resistant A549 Non-small Cell Lung Cancer Cells

  2013cites this paper
• TRAIL-induced kinases activation and apoptosis: towards improved death receptor targeted therapy for lung cancer

  2013cites this paper
• University of Groningen TRAIL-induced kinases activation and apoptosis Azijli, Kaamar

  2013cites this paper
• Reconstruction of an Integrated Genome-Scale Co-Expression Network Reveals Key Modules Involved in Lung Adenocarcinoma

  2013cites this paper